Long COVID and Other Post-Acute Infection Syndromes (F1)
August 10-13, 2025
| Eldorado Hotel & Spa, Santa Fe, NM, United States
Akiko Iwasaki, Avindra Nath, Hannah Davis and Daniel M. Altmann
Scholarship Deadline: May. 28, 2025 | Abstract Deadline: Jul. 18, 2025 | Early Registration Deadline: Jun. 25, 2025
| 4:00–8:00 PM |
Registration |
Concourse |
| 6:00–8:00 PM |
Welcome Mixer |
Cava Santa Fe |
| 7:00–8:00 AM |
Breakfast |
Anasazi Ballroom |
| 7:30–8:00 AM |
Poster Setup |
Anasazi Ballroom |
| 7:30–5:00 PM |
Poster Viewing |
Anasazi Ballroom |
| 8:00–9:00 AM |
Welcome and Keynote Address |
Eldorado Ballroom |
| |
* Akiko Iwasaki, Yale University/HHMI
|
|
| |
Michael J Peluso, University of California, San Francisco
Long COVID: What We have Learned so far and What Needs to Happen Next |
|
| 9:00–11:15 AM |
Epidemiology, Clinical Diagnosis and Management of Long COVID |
Eldorado Ballroom |
| |
* Hannah Davis, Patient-Led Research Collaborative
Two patterns in Long Covid: Craniocervical Instability and Illness Duration |
|
| |
Ziyad Al-Aly, Washington University School of Medicine
Epidemiology of Long COVID |
|
| |
David Putrino, Mount Sinai School of Medicine
Clinical Diagnosis and Management of Long COVID |
|
| |
Michelle J L Scoullar, Burnet Institute
Short Talk: A Narrative Review of the Impact, Treatment and Outcomes of Paediatric Long COVID, Including the Prevalence of Dysautonomia, From A Specialist Long COVID Clinic in Australia |
|
| 9:30–9:50 AM |
Coffee Break |
Concourse |
| 11:15–12:15 PM |
Lunch |
Anasazi Ballroom |
| 11:20–12:15 PM |
Women in Science Networking Session |
Eldorado Ballroom |
| |
* Emma C Wall, The Francis Crick Institute
|
|
| |
* Nadia R. Roan, University of California, San Francisco
|
|
| |
* Esther Melamed, Dell Medical School
|
|
| |
* Hanna Ollila, University of Helsinki and Harvard University
|
|
| |
* Courtney Malo, Science Translational Medicine
|
|
| 11:45–2:15 PM |
Poster Session 1 |
Anasazi Ballroom |
| 2:15–4:30 PM |
Symposia Spotlight: Featured Abstract Presentations |
Eldorado Ballroom |
| |
Amelie Bos, University Medical Centre Amsterdam
An In Vitro Model for Long-COVID Using Skeletal Muscle Cultures and Patient Plasma |
|
| |
* Timothy J. Henrich, University of California, San Francisco
Multi-Omic Analysis of Bone Marrow from People with and Without Long COVID Reveals Lymphoproliferative Disorders and Immune Dysregulation but Not SARS-CoV-2 Persistence |
|
| |
Penelope Markham, BioVie
A Phase 2 Trial Designed to Enhance Signal Detection in an Evaluation of Bezisterim (NE3107) For the Treatment of Neurological Symptoms of Long COVID |
|
| |
Claire S Laxton, Yale University
Development of a Multiplex qPCR To Detect Herpesvirus Reactivation and Shedding Dynamics in Saliva of Long Covid Patients |
|
| |
Emma C Wall, The Francis Crick Institute
An Innate Inflammatory Signature Is Consistently Enriched in the Plasma of Adults Living with Long COVID Across all Clinical Symptom Groups |
|
| |
Nadia R. Roan, University of California, San Francisco
Inhibition of CXCR4 Signaling Reverses Behavioral Abnormalities in a Mouse Model of Long COVID |
|
| |
Esther Melamed, Dell Medical School
Analysis of 977 Long COVID Patients Reveals Prevalent Neuropathy and Association with Anti-Ganglioside Antibodies |
|
| |
Michela Locci, University of Pennsylvania
Alterations of B Cell Responses to SARS-CoV-2 in Long COVID |
|
| |
Hung-Jen Chen, University of Amsterdam, Amsterdam University Medical Centers
Long COVID and Autoimmunity: Transfer of IgG from Long COVID Patients Induces Symptomology in Mice |
|
| 4:30–5:00 PM |
Coffee Available |
Concourse |
| 5:00–7:00 PM |
Immunological Dysfunction and Mechanisms of Long COVID |
Eldorado Ballroom |
| |
* Daniel M. Altmann, Imperial College London
Immune Signatures of Long COVID |
|
| |
E. John Wherry, University of Pennsylvania
Using T Cells as Biosensors in Long COVID |
|
| |
Akiko Iwasaki, Yale University/HHMI
Immunological Mechanisms of Long COVID |
|
| |
August Jernbom, KTH Royal Institute of Technology / Johns Hopkins University
Short Talk: Prevalent and Persistent New-Onset Autoantibodies in Mild to Severe COVID-19 |
|
| |
Shubha Talwar, Imperial College London
Short Talk: Investigating the Role of Autoantibodies in Long-Lasting Respiratory Symptoms Post-COVID-19 |
|
| 7:00–8:00 PM |
On Own for Dinner |
|
| 7:00–8:00 AM |
Breakfast |
Anasazi Ballroom |
| 8:00–10:30 AM |
Post-Acute Infection Syndromes |
Eldorado Ballroom |
| |
Lisa F.P. Ng, Infectious Diseases Labs, ASTAR
Post-Chikungunya Virus Autoimmune Syndrome |
|
| |
* Michal Caspi Tal, Massachusetts Institute of Technology
Unraveling the Immunopathology of Borrelia Infection-Associated Chronic Illnesses: Sex Differences and Predictive Diagnostics |
|
| |
Maureen R. Hanson, Cornell University
Immune Signaling in ME/CFS |
|
| |
Jalene Velazquez, Washington State University
Short Talk: Distinct Antibody Effector Profiles Track with the Development of Post-Ebola Syndrome |
|
| |
Maia M Madison, UCSF
Short Talk: Cytokine Biomarkers for Differential Diagnosis of Persistent Lyme Disease and Other Infection-Associated Chronic Illnesses |
|
| 9:00–9:20 AM |
Coffee Break |
Concourse |
| 9:20–9:25 AM |
Award Recipient Acknowledgement |
Eldorado Ballroom |
| 10:30–1:00 PM |
Poster Setup |
Anasazi Ballroom |
| 10:30–3:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
Anasazi Ballroom |
| 1:45–2:45 PM |
Career Roundtable |
Eldorado Ballroom |
| |
Roshan Kumar, HiFiBiO Therapeutics
Executive Director, Head of Research and External Innovation |
|
| |
Vidhya Vijayakumar, Draper Labs
Principal Member of Technical Staff |
|
| |
Annukka A Antar, Johns Hopkins School of Medicine
Assistant Professor |
|
| 3:00–4:30 PM |
Panel Discussion: Long COVID: Mechanisms, Diagnosis, and Emerging Treatments |
Eldorado Ballroom |
| |
* Maggie Bartlett, Global Virus Network & Johns Hopkins School of Public Health
Moderator |
|
| |
* Sten H. Vermund, University of South Florida
Moderator |
|
| |
Akiko Iwasaki, Yale University/HHMI
|
|
| |
Anders G. Vahlne, Karolinska Institutet
|
|
| |
Resia Pretorius, Stellenbosch University
|
|
| |
Janet M Mullington, BIDMC & Harvard Medical School
|
|
| |
Annukka A Antar, Johns Hopkins School of Medicine
|
|
| 4:30–5:00 PM |
Coffee Available |
Concourse |
| 5:00–7:00 PM |
Gut, Sex and other Influences on the Manifestation of PAIS |
Eldorado Ballroom |
| |
Sabra L. Klein, Johns Hopkins University
Remote Presentation: Sex Differences in Long COVID Revealed by Animal Models |
|
| |
* Maayan Levy, Stanford University
The Role of Persistent Gut Infection in Long COVID |
|
| |
Vivian Vasconcelos C Litwinski, Federal University of Minas Gerais
After the Virus: Mechanisms Driving Post-Viral Sequelae |
|
| |
Brian H LaFranchi, UCSF
Short Talk: Deep Multi-Omic Analysis of Colorectal Tissues from People with and Without Long COVID Demonstrates SARS-CoV-2 Persistence and Immune Dysregulation Years After Initial Infection |
|
| |
James Chung, University of Missouri
Short Talk: Facilitating Mouse Studies of Long COVID |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
Anasazi Ballroom |
| 7:30–10:00 PM |
Poster Session 2 |
Anasazi Ballroom |
Wednesday, August 13, 2025
| 7:00–8:00 AM |
Breakfast |
Anasazi Ballroom |
| 8:00–11:00 AM |
Neurological and Vascular Damages in Long COVID |
Eldorado Ballroom |
| |
Petter Brodin, Karolinska Institutet
Viral Persistence and Regulation of Immunity in PACS |
|
| |
* Avindra Nath, NINDS, National Institutes of Health
Neurological Complications in Long COVID and ME CFS |
|
| |
Jennifer Frontera, New York University
Neurodegenerative Diseases Following COVID-19 |
|
| |
Joga R. Chaganti, Thomas Jefferson University Hospital
Imaging Correlates of Dysfunction in Glymphatic System, Blood Brian Barrier and Explore Glutamatergic Excitotoxicity in Long Covid |
|
| |
Lindsay McAlpine, Yale University School of Medicine
Short Talk: Cerebrospinal Fluid Alterations & Proteomics in Neuropsychiatric Long COVID |
|
| |
Alba Azola, Johns Hopkins School of Medicine
Short Talk: Blood-Brain Barrier Disruption in Long COVID and Cognitive Correlates |
|
| 9:00–9:20 AM |
Coffee Break |
Concourse |
| 11:00–1:00 PM |
Poster Setup |
Anasazi Ballroom |
| 11:00–2:15 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
Anasazi Ballroom |
| 2:30–4:30 PM |
Understudied Topics in PAIS |
Eldorado Ballroom |
| |
Roshan Kumar, HiFiBiO Therapeutics
T Cell Dysregulation Revealed by Single-Cell TCR Repertoire & Expression Profiling of Long COVID and ME/CFS Patients |
|
| |
Hideki Ueno, Graduate School of Medicine, Kyoto University
Sex Differences in Immune Responses Shape Long COVID Pathogenesis |
|
| |
Cherie L Marvel, Johns Hopkins University
Functional brain imaging and outcomes in long COVID and post treatment Lyme disease |
|
| |
Paige Hansen Colburn, Massachusetts Institute of Technology
Lyme Disease Increases Risk for Multiple Gynecological Conditions |
|
| |
* John N Aucott, Johns Hopkins University
The Concurrence of Post-Treatment Lyme Disease, Fibromyalgia, and ME/CFS |
|
| |
Bronwyn M Gunn, Washington State University
Humoral Immune Correlates of Orthoebolavirus Sudanese RNA Persistence in Semen |
|
| |
Abigail Vanderheiden, Washington University in St. Louis
Dural CD4+ T Cells Promote Hippocampal Memory Deficits in a Mouse Model of COVID-19 |
|
| |
Bornali Bhattacharjee, Yale University
Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination |
|
| 4:30–5:00 PM |
Coffee Available |
Concourse |
| 5:00–6:15 PM |
Clinical and Translational Approaches in PAIS |
Eldorado Ballroom |
| |
* E. Wesley Ely, Vanderbilt University Medical Center
Reverse-LC Baricitinib Trial for Long COVID |
|
| |
Amitava Banerjee, University College London
Insights from STIMULATE-ICP |
|
| |
Giulia Unali, Boston University
Short Talk: Bone Marrow Hematopoietic Impairment in a Humanized Mouse Model of Post-acute Sequelae of COVID-19 |
|
| 6:15–6:30 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
Eldorado Ballroom |
| 6:30–7:30 PM |
Social Hour with Dinner |
Anasazi Ballroom |
| 7:30–10:00 PM |
Poster Session 3 |
Eldorado Ballroom |
Thursday, August 14, 2025
